Table 2.
Biopolymeric Delivery Systems for Encapsulation of Nutraceuticals
| Bioactive Compound Category | Bioactive Compound | Nature-Derived Polymer Used | Advantage of Nanoencapsulation | Reference |
|---|---|---|---|---|
| Polyphenols | Curcumin | Chitosan and gum arabica | Improved stability and antioxidant activity of curcumin | (Tan et al., 2016) |
| Curcumin | Soluble soya bean polysaccharides | Improved the anti-cancer property of curcumin | (Pan et al., 2018) | |
| Resveratrol | Chitosan/γ-poly (glutamic acid) | Improved the solubility and cellular uptake | (Jeon et al., 2016) | |
| Resveratrol | Zeina | Improved bioavailability | (Jayan et al., 2019) | |
| Lutein | Chitosan/poly-glutamic acid | Improved the solubility | (Lee and Lee, 2016) | |
| Green tea catechins | Zeina | Improved cell uptake | (Bhushani et al., 2017) | |
| Carotenoids | Beta carotene | Starcha | Intestine specific release of beta carotene | (Santoyo-Aleman et al., 2019) |
| Lutein | Starcha | Improved solubility and stability of lutein | (Fu et al., 2019) | |
| Lycopene | Zeina | Improved antioxidant activity | (Horuz and Belibagli, 2019) | |
| Vitamins | Folate B9 | Whey protein isolate and resistant starch | Improved stability of folic acid | (Pérez-Masiá et al., 2015) |
| Cobalamin B12 | Soy protein | Improved intestinal transport | (Zhang et al., 2015) | |
| Vitamin D | Fish oil | Improved bioavailability | (Walia et al., 2017) |
a
Considered GRAS by FDA (21 CFR Ch. I [4–1–11 Edition]).